BHC (Bausch Health) Insider Ownership: 4.31 % (As of Aug. 01, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BHC Bausch Health Companies Inc BHC
64 GF Score
Price $6.89
GF Value $7.73
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Bausch Health Insider Ownership?

Bausch Health BHC +14.26% 64 Insider Ownership is 4.31 % as of Aug. 01, 2026. GuruFocus rates BHC with a GF Score™ of 64/100 and a GF Value™ of $7.73 (Fairly Valued). The stock has 3 warning signs investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Bausch Health's insider ownership is 4.31%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Bausch Health's Institutional Ownership is 62.27%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Bausch Health's Float Percentage Of Total Shares Outstanding is 79.85%.

Bausch Health Insider Ownership Historical Data

* Premium members only.

The historical data trend for Bausch Health's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bausch Health Insider Ownership Chart

Bausch Health Historical Data

The historical data trend for Bausch Health can be seen below:

2025-06-30 2025-07-31 2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30
Insider Ownership 3.95 3.98 3.97 3.96 3.95 3.95 3.95 4.65 4.31 4.31
BHC
64GF Score
Bausch Health Companies Inc BHC
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bausch Health Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 4.31 % mean?
Bausch Health (BHC) has a Insider Ownership of 4.31 % as of Aug. 01, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Bausch Health and its competitors.
Is Bausch Health's Insider Ownership too high?
Bausch Health's current Insider Ownership is 4.31 %. Overall, Bausch Health has a GF Score™ of 64/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bausch Health's Insider Ownership compare to ZTS?
Bausch Health's Insider Ownership of 4.31 % can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Drug Manufacturers company?
A good Insider Ownership depends on the Drug Manufacturers industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Bausch Health and its competitors. Bausch Health's current Insider Ownership is 4.31 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bausch Health stock overvalued right now?
Based on GuruFocus' analysis, Bausch Health (BHC) is currently considered Fairly Valued. The stock's GF Value™ is $7.73, compared to a current price of $6.89 — trading 10.9% below its estimated fair value. The current Insider Ownership is 4.31 %. Bausch Health's overall GF Score™ is 64/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Bausch Health (BHC), the current Insider Ownership is 4.31 % as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bausch Health (BHC) Overvalued in 2026?

Based on GuruFocus' analysis, Bausch Health stock appears to be undervalued. The current stock price of $6.89 is trading 10.9% below its estimated GF Value™ of $7.73. GuruFocus considers Bausch Health to be Fairly Valued.

Key valuation signals for BHC:

  • Insider Ownership: 4.31 %
  • GF Value™: $7.73 vs. price of $6.89 (10.9% below fair value)
  • GF Score™: 64/100 with 3 warning signs

No single metric tells the full story. See the BHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bausch Health Business Description

Address 2150 St Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
64GF Score

Get the complete analysis for BHC

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.89
Price
$7.73
GF Value